China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of pituitrin for pulmonary tuberculosis-associated hemoptysis: a multicenter retrospective cohort study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129719
Registration Time: 2026/08/09
Type: Observational study
Primary Sponsor: The Third People’s Hospital of Shenzhen
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325030
Published by HT Digital Content Services with permission from Health Daily Digest....